Hendrik Dietrich

Summary

Affiliation: Actelion Pharmaceuticals Ltd
Country: Switzerland

Publications

  1. ncbi Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant
    Hendrik Dietrich
    Research and Development, Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, CH 4123 Allschwil, Switzerland
    Psychopharmacology (Berl) 212:145-54. 2010

Detail Information

Publications1

  1. ncbi Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant
    Hendrik Dietrich
    Research and Development, Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, CH 4123 Allschwil, Switzerland
    Psychopharmacology (Berl) 212:145-54. 2010
    ..Almorexant, a dual orexin receptor antagonist, transiently and reversibly blocks the action of orexin peptides at both OX(1) and OX(2) receptors and increases time spent in rapid eye movement (REM) and non-REM sleep...